Stock ONCT ONCTERNAL THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Oncternal Therapeutics, Inc.

Equities

ONCT

US68236P2065

Market Closed - Nasdaq
Other stock markets
 02:00:00 06/06/2024 am IST 		5-day change 1st Jan Change
8.8 USD +3.53% Intraday chart for Oncternal Therapeutics, Inc. -3.40% -17.94%
30/05 Oncternal Announces Enrollment Completed and Dosing Initiated for Fifth Dose Cohort of Phase 1/2 Study of Onct-534 for the Treatment of R/R Metastatic Castration-Resistant Prostate Cancer CI
09/05 Transcript : Oncternal Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
ONCTERNAL THERAPEUTICS, INC.
Other Biotechnology & Medical Research
+3.53%-3.40%-17.94%+42.49% - 2.6Cr
Neutral
Neutral
Neutral

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. ONCT Stock
  4. Charts Oncternal Therapeutics, Inc.
  5. Comparison Chart